Onconova Therapeutics Inc. (NASDAQ:ONTX) went up by 0.09% from its latest closing price compared to the recent 1-year high of $1.56. The company’s stock price has collected 36.32% of gains in the last five trading sessions. Press Release reported on 01/07/21 that Onconova Therapeutics, Inc. Announces $8.7 Million Public Offering
Is It Worth Investing in Onconova Therapeutics Inc. (NASDAQ :ONTX) Right Now?
Plus, the 36-month beta value for ONTX is at 1.94. Opinions of the stock are interesting as 1 analysts out of 4 who provided ratings for Onconova Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 3 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $0.46. ONTX currently public float of 183.78M and currently shorts hold a 5.32% ratio of that float. Today, the average trading volume of ONTX was 22.37M shares.
ONTX’s Market Performance
ONTX stocks went up by 36.32% for the week, with a monthly jump of 102.42% and a quarterly performance of 129.24%, while its annual performance rate touched 38.62%. The volatility ratio for the week stands at 34.88% while the volatility levels for the past 30 days are set at 21.03% for Onconova Therapeutics Inc.. The simple moving average for the period of the last 20 days is 41.18% for ONTX stocks with a simple moving average of 38.21% for the last 200 days.
Analysts’ Opinion of ONTX
Many brokerage firms have already submitted their reports for ONTX stocks, with H.C. Wainwright repeating the rating for ONTX by listing it as a “Buy.” The predicted price for ONTX in the upcoming period, according to H.C. Wainwright is $7.50 based on the research report published on March 01st of the previous year 2018.
H.C. Wainwright gave a rating of “Buy” to ONTX, setting the target price at $6 in the report published on October 09th of the previous year.
ONTX Trading at 83.64% from the 50-Day Moving Average
After a stumble in the market that brought ONTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -59.29% of loss for the given period.
Volatility was left at 21.03%, however, over the last 30 days, the volatility rate increased by 34.88%, as shares surge +98.93% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +143.67% upper at present.
During the last 5 trading sessions, ONTX rose by +36.32%, which changed the moving average for the period of 200-days by +78.62% in comparison to the 20-day moving average, which settled at $0.4656. In addition, Onconova Therapeutics Inc. saw 36.32% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at ONTX starting from OLER ABRAHAM N., who purchase 30,000 shares at the price of $0.32 back on Dec 11. After this action, OLER ABRAHAM N. now owns 140,000 shares of Onconova Therapeutics Inc., valued at $9,600 using the latest closing price.
Guerin Mark Patrick, the Chief Financial Officer of Onconova Therapeutics Inc., purchase 4,614 shares at $0.26 during a trade that took place back on Nov 27, which means that Guerin Mark Patrick is holding 130,213 shares at $1,200 based on the most recent closing price.
Stock Fundamentals for ONTX
Current profitability levels for the company are sitting at:
- -994.00 for the present operating margin
The net margin for Onconova Therapeutics Inc. stands at -985.02. The total capital return value is set at -255.87, while invested capital returns managed to touch -253.56. Equity return is now at value -161.10, with -89.70 for asset returns.
The receivables turnover for the company is 32.83 and the total asset turnover is 0.10. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.83.